000			01981 a2200613 4500
005			20250513085904.0
264		0	_c19960517
008			199605s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aFay, J W
245	0	0	_aFK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. _h[electronic resource]
260			_bBlood _cApr 1996
300			_a3514-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBiological Availability
650	0	4	_aBone Marrow Transplantation _xadverse effects
650	0	4	_aChemical and Drug Induced Liver Injury
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xepidemiology
650	0	4	_aHistocompatibility
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aIncidence
650	0	4	_aKidney Diseases _xchemically induced
650	0	4	_aLeukemia _xmortality
650	0	4	_aLife Tables
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyelodysplastic Syndromes _xmortality
650	0	4	_aNuclear Family
650	0	4	_aParity
650	0	4	_aSafety
650	0	4	_aSurvival Analysis
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aTissue Donors
650	0	4	_aTransplantation, Homologous _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aWingard, J R
700	1		_aAntin, J H
700	1		_aCollins, R H
700	1		_aPiñeiro, L A
700	1		_aBlazar, B R
700	1		_aSaral, R
700	1		_aBierer, B E
700	1		_aPrzepiorka, D
700	1		_aFitzsimmons, W E
700	1		_aMaher, R M
700	1		_aWeisdorf, D J
773	0		_tBlood _gvol. 87 _gno. 8 _gp. 3514-9
999			_c8604421 _d8604421